Lombard Medical, Inc. (EVARF) Research

Lombard Medical, Inc. is a medical technology firm specializing in the creation, production, and distribution of endovascular stent-grafts designed for the repair of aortic aneurysms. The company serves a global market, with operations in the United States, United Kingdom, Germany, Japan, and other international regions. Its leading offering, Aorfix, is an endovascular stent-graft specifically engineered to address abdominal aortic aneurysms (AAAs) where the aneurysm's neck exhibits significant angulation, up to 90 degrees. Other solutions include the Altura endovascular stent graft system, tailored for more conventional AAA anatomies. Furthermore, Lombard Medical provides sophisticated delivery mechanisms: the Aorflex system ensures precise deployment of Aorfix within the abdominal aorta, while the IntelliFlex LP system further enhances the accuracy and control during Aorfix placement and deployment. The firm distributes its products through both its proprietary sales force and a network of distributors, primarily targeting state- or government-operated hospitals. Established in 2000, Lombard Medical, Inc. maintains its corporate headquarters in Didcot, United Kingdom.

Open Lombard Medical, Inc. (EVARF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.